You have searched for "Brazil"
Showing 1-10 of 10000
Asian shares were mostly higher on Tuesday with hopes growing for a global economic rebound despite surging coronavirus cases in many places.
NEW DELHI (Reuters) -India is to fast-track emergency approvals for COVID-19 vaccines that have been authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson, and Moderna shots.
NEW YORK: The dollar fell slightly on Monday and a gauge of global equity markets slid from record highs last week as investors wait to see whether an expected jump in U.S. earnings will justify stock prices already trading at very high premiums.
PETALING JAYA: China’s Sinovac vaccine is safe to be administered to senior citizens under the second phase of the National Covid-19 Immunisation Programme.
GENEVA (Reuters) -Confusion and complacency in addressing COVID-19 means the pandemic is a long way from over, but it can be brought under control in months with proven public health measures, WHO Director-General Tedros Adhanom Ghebreyesus said on Monday.
BENGALURU (Reuters) - India has approved the use of Russia's "Sputnik V" vaccine against COVID-19 based on strong immunogenicity data, the Economic Times newspaper reported on Monday.
The coronavirus pandemic continued its second, steep spike in India on Monday, with the country overtaking Brazil as the country with the second-largest Covid-19 caseload after the United States.
PETALING JAYA: Senior citizens aged 60 and above can be given the Sinovac vaccine under phase two of the National Covid-19 Immunisation Programme, says Khairy Jamaluddin.
NEW DELHI, (Reuters) -Hundreds of thousands of Hindu devotees flocked on Monday to take a holy bath in India's Ganges river, even as the nation racked up the world's highest tally of new daily coronavirus infections.
Chinese shots have reached more than 60 countries so far, as rich nations guard their doses for mass inoculation at homeBut the vaccines are still under review for WHO authorisation, and concerns remain over efficacy and data transparency